Total revenue reached $119.6 million for the quarter, and gross profit was $98.6 million, up 82.4 percent from the second quarter of last year. The total GAAP operating expenses for the second quarter were $90.3 million as compared to $86.7 million for last year’s second quarter and $86.7 million for the first quarter 2010.
Cash, cash equivalents and short and long-term marketable securities were at $213.2 million on June 30, 2010, while operation cash flow was $16.3 million for the second quarter of 2010.
Read the NuVasive report on the 2010 2Q FY results.
Read other coverage on NuVasive:
– Two Insurers Reverse Policies to Cover XLIF Procedures
– Vail-Summit Spine Surgeon First to Use MAS-TLIF for Minimally Invasive Spine Fusion
– Spine Surgery Company NuVasive Reports 42 Percent Sales Increase
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
